Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Trailhead Biosystems Pulls In $6.6M Series A

2020-11-10
CLEVELAND, OH, Trailhead Biosystems has announced its $6.6 million Series A financing.
Trailhead Biosystems - a biotechnology company pioneering the application of machine-enabled science towards understanding and controlling biology - announced its $6.6 million Series A financing. The company has developed a proprietary platform to perform systems-level interrogation of complex biological problems, ranging from the generation of industrially-scalable manufacturing conditions for specialized human cells to combinatorial drug discovery in cancer and anti-viral therapies. Trailhead robotically conducts the largest dimensioned experiments in biology, using machine learning to discover critical process parameters and combinatorial inputs that explain biological responses. Trailhead's groundbreaking methods depart radically from the limited explorative power of standard hypothesis-driven research.

Trailhead Biosystems is pioneering the development of cell-based therapeutics using machine learning and bioinformatics. Trailhead's High Dimensional Design of Experiments (HD-DoE) platform merges developmental biology and cell therapeutics with advanced robotics, computerized experimental design, and analysis to perform process-specific parameter optimization in the development of cell therapies.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors